Low levels of TGF-β1 enhance human umbilical cord-derived mesenchymal stem cell fibronectin production and extend survival time in a rat model of lipopolysaccharide-induced acute lung injury

Li,Dong; Liu,Qingshen; Qi,Lei; Dai,Xiaoyu; Liu,Huan; Wang,Yunshan

doi:10.3892/mmr.2016.5416

Low levels of TGF-β1 enhance human umbilical cord-derived mesenchymal stem cell fibronectin production and extend survival time in a rat model of lipopolysaccharide-induced acute lung injury

Authors:
- Dong Li
- Qingshen Liu
- Lei Qi
- Xiaoyu Dai
- Huan Liu
- Yunshan Wang
View Affiliations

Affiliations: Cryomedicine Laboratory, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China, First Department of Surgery, Hospital Affiliated to Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250014, P.R. China, Central Laboratory, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250100, P.R. China
Published online on: June 21, 2016 https://doi.org/10.3892/mmr.2016.5416
Pages: 1681-1692

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Mesenchymal stem cells (MSCs) are an attractive cellular source for cell‑based therapy, tissue engineering and regenerative medicine. However, the use of MSCs is limited by their low incorporation rate in the graft environment. The majority of cells are lost from the graft within 1 month, due to reduced microenvironment or local inflammation at the graft site. The extracellular matrix (ECM) may assist the survival and expansion of MSCs. The present study aimed to identify an effective approach to increase ECM expression levels by MSCs in order to enhance the therapeutic effect and survival rate of MSCs at the injury site. The concentration‑dependent effect of transforming growth factor (TGF)‑β1 on human umbilical cord (hUC)‑MSC proliferation and expression of ECM genes was investigated. MSCs were successfully isolated, cultured and expanded from hUC. A low concentration of TGF‑β1 (0.1 ng/ml) exhibited the optimal effect on hUC‑MSC proliferation and markedly stimulated the expression of ECM genes, particularly fibronectin (FN). Furthermore, treatment with TGF‑β1 caused no alteration in the immunophenotype and differentiation capacity of MSCs. In vivo experiments in rats demonstrated that intravenous injection of control UC-MSCs or TGF-β1-pre-treated UC-MSCs reduced the severity of lipopolysaccharide-induced lung injury, assessed using histology, measurements of the wet‑dry lung weight ratio, and neutrophil count and protein concentration in bronchoalveolar lavage fluid. However, the short‑term (48 h) therapeutic effects of untreated and TGF‑β1‑pre‑treated UC‑MSCs were similar. The survival of MSCs in damaged lungs, determined by Sry gene expression levels, were significantly increased in MSCs pre‑treated with TGF‑β1. In conclusion, pre‑treatment of MSCs with a low concentration of TGF‑β1 enhanced the expression of ECM components, particularly FN, thus, improving the survival and potential therapeutic benefits of MSCs. Pre‑treatment of MSCs with TGF‑β1 may prolong the effective therapy time and represent an efficient therapeutic approach for tissue repair.

View Figures

View References

1	Pittenger MF and Martin BJ: Mesenchymal stem cells and their potential as cardiac therapeutics. Cir Res. 95:9–20. 2004. View Article : Google Scholar
2	Wu KH, Tsai C, Wu HP, Sieber M, Peng CT and Chao YH: Human application of ex vivo expanded umbilical cord-derived mesenchymal stem cells: Enhance hematopoiesis after cord blood transplantation. Cell Transplant. 22:2041–2051. 2013. View Article : Google Scholar : PubMed/NCBI
3	Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M and Ringdén O: Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 363:1439–1441. 2004. View Article : Google Scholar : PubMed/NCBI
4	Sudres M, Norol F, Trenado A, Grégoire S, Charlotte F, Levacher B, Lataillade JJ, Bourin P, Holy X, Vernant JP, et al: Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice. J Immunol. 176:7761–7767. 2006. View Article : Google Scholar : PubMed/NCBI
5	Marion NW and Mao JJ: Mesenchymal stem cells and tissue engineering. Methods Enzymol. 420:339–361. 2006. View Article : Google Scholar : PubMed/NCBI
6	Shi S, Bartold PM, Miura M, Seo BM, Robey PG and Gronthos S: The efficacy of mesenchymal stem cells to regenerate and repair dental structures. Orthod Craniofac Res. 8:191–199. 2005. View Article : Google Scholar : PubMed/NCBI
7	Fiedler J, Etzel N and Brenner RE: To go or not to go: Migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF. J Cell Biochem. 93:990–998. 2004. View Article : Google Scholar : PubMed/NCBI
8	Gao J and Caplan AI: Mesenchymal stem cells and tissue engineering for orthopaedic surgery. Chir Organi Mov. 88:305–316. 2003.In English, Italian.
9	Tuan RS, Boland G and Tuli R: Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther. 5:32–45. 2003. View Article : Google Scholar : PubMed/NCBI
10	Hsiao ST, Asgari A, Lokmic Z, Sinclair R, Dusting GJ, Lim SY and Dilley RJ: Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue. Stem Cells Dev. 21:2189–2203. 2012. View Article : Google Scholar :
11	Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W, Han ZB, Xu ZS, Lu YX, Liu D, et al: Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica. 91:1017–1026. 2006.PubMed/NCBI
12	Liu S, Yuan M, Hou K, Zhang L, Zheng X, Zhao B, Sui X, Xu W, Lu S and Guo Q: Immune characterization of mesenchymal stem cells in human umbilical cord Wharton's jelly and derived cartilage cells. Cell Immunol. 278:35–44. 2012. View Article : Google Scholar : PubMed/NCBI
13	Peng J, Wang Y, Zhang L, Zhao B, Zhao Z, Chen J, Guo Q, Liu S, Sui X, Xu W and Lu S: Human umbilical cord Wharton's jelly-derived mesenchymal stem cells differentiate into a Schwann-cell phenotype and promote neurite outgrowth in vitro. Brain Res Bull. 84:235–243. 2011. View Article : Google Scholar : PubMed/NCBI
14	Tamama K, Kawasaki H and Wells A: Epidermal growth factor (EGF) treatment on multipotential stromal cells (MSCs). Possible enhancement of therapeutic potential of MSC. J Biomed Biotechnol. 2010:7953852010. View Article : Google Scholar : PubMed/NCBI
15	Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L, Palasis M and Wilensky RL: A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J. 27:1114–1122. 2006. View Article : Google Scholar : PubMed/NCBI
16	Song H, Song BW, Cha MJ, Choi IG and Hwang KC: Modification of mesenchymal stem cells for cardiac regeneration. Expert Opin Biol Ther. 10:309–319. 2010. View Article : Google Scholar : PubMed/NCBI
17	Thibault MM, Hoemann CD and Buschmann MD: Fibronectin, vitronectin, and collagen I induce chemotaxis and haptotaxis of human and rabbit mesenchymal stem cells in a standardized transmembrane assay. Stem Cells Dev. 16:489–502. 2007. View Article : Google Scholar : PubMed/NCBI
18	Basile DP, Martin DR and Hammerman MR: Extracellular matrix-related genes in kidney after ischemic injury: Potential role for TGF-beta in repair. Am J Physiol. 275:F894–F903. 1998.PubMed/NCBI
19	Lee JH, Yu HS, Lee GS, Ji A, Hyun JK and Kim HW: Collagen gel three-dimensional matrices combined with adhesive proteins stimulate neuronal differentiation of mesenchymal stem cells. J R Soc Interface. 8:998–1010. 2011. View Article : Google Scholar : PubMed/NCBI
20	O'Callaghan CJ and Williams B: Mechanical strain-induced extracellular matrix production by human vascular smooth muscle cells: Role of TGF-beta(1). Hypertension. 36:319–324. 2000. View Article : Google Scholar : PubMed/NCBI
21	Lee YC and Rannels DE: Regulation of extracellular matrix synthesis by TNF-alpha and TGF-beta1 in type II cells exposed to coal dust. Am J Physiol. 275:L637–L644. 1998.PubMed/NCBI
22	Baarsma HA, Menzen MH, Halayko AJ, Meurs H, Kerstjens HA and Gosens R: β-Catenin signaling is required for TGF-β1-induced extracellular matrix production by airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 301:L956–L965. 2011. View Article : Google Scholar : PubMed/NCBI
23	Ng F, Boucher S, Koh S, Sastry KS, Chase L, Lakshmipathy U, Choong C, Yang Z, Vemuri MC, Rao MS and Tanavde V: PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): Transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood. 112:295–307. 2008. View Article : Google Scholar : PubMed/NCBI
24	Jian H, Shen X, Liu I, Semenov M, He X and Wang XF: Smad3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Genes Dev. 20:666–674. 2006. View Article : Google Scholar : PubMed/NCBI
25	Park WS, Heo SC, Jeon ES, Hong da H, Son YK, Ko JH, Kim HK, Lee SY, Kim JH and Han J: Functional expression of smooth muscle-specific ion channels in TGF-β(1) -treated human adipose-derived mesenchymal stem cells. Am J Physiol Cell Physiol. 305:C377–C391. 2013. View Article : Google Scholar : PubMed/NCBI
26	Huang F, Zhu X, Hu XQ, Fang ZF, Tang L, Lu XL and Zhou SH: Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival. Int J Mol Med. 31:484–492. 2013.
27	Jurewicz M, Yang S, Augello A, Godwin JG, Moore RF, Azzi J, Fiorina P, Atkinson M, Sayegh MH and Abdi R: Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes. Diabetes. 59:3139–3147. 2010. View Article : Google Scholar : PubMed/NCBI
28	Curley GF, Hayes M, Ansari B, Shaw G, Ryan A, Barry F, O'Brien T, O'Toole D and Laffey JG: Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat. Thorax. 67:496–501. 2012. View Article : Google Scholar
29	Hu KX, Sun QY, Guo M and Ai HS: The radiation protection and therapy effects of mesenchymal stem cells in mice with acute radiation injury. Br J Radiol. 83:52–58. 2010. View Article : Google Scholar : PubMed/NCBI
30	Zoja C, Garcia PB, Rota C, Conti S, Gagliardini E, Corna D, Zanchi C, Bigini P, Benigni A, Remuzzi G and Morigi M: Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathy. Am J Physiol Renal Physiol. 303:F1370–F1381. 2012. View Article : Google Scholar : PubMed/NCBI
31	Prockop DJ: Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 276:71–74. 1997. View Article : Google Scholar : PubMed/NCBI
32	Rodrigues M, Griffith LG and Wells A: Growth factor regulation of proliferation and survival of multipotential stromal cells. Stem Cell Res Ther. 1:322010. View Article : Google Scholar : PubMed/NCBI
33	Locklin RM, Oreffo RO and Triffitt JT: Effects of TGFbeta and bFGF on the differentiation of human bone marrow stromal fibroblasts. Cell Biol Int. 23:185–194. 1999. View Article : Google Scholar : PubMed/NCBI
34	Huang SS and Huang JS: TGF-beta control of cell proliferation. J Cell Biochem. 96:447–462. 2005. View Article : Google Scholar : PubMed/NCBI
35	Roberts AB: Molecular and cell biology of TGF-beta. Miner Electrolyte Metab. 24:111–119. 1998. View Article : Google Scholar : PubMed/NCBI
36	Singh P and Schwarzbauer JE: Fibronectin and stem cell differentiation-lessons from chondrogenesis. J Cell Sci. 125:3703–3712. 2012. View Article : Google Scholar : PubMed/NCBI
37	Singh P, Carraher C and Schwarzbauer JE: Assembly of fibronectin extracellular matrix. Ann Rev Cell Dev Biol. 26:397–419. 2010. View Article : Google Scholar
38	Yurchenco PD and Patton BL: Developmental and pathogenic mechanisms of basement membrane assembly. Curr Pharm Des. 15:1277–1294. 2009. View Article : Google Scholar : PubMed/NCBI
39	George EL, Georges-Labouesse EN, Patel-King RS, Rayburn H and Hynes RO: Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development. 119:1079–1091. 1993.PubMed/NCBI
40	Schwartz MA and Assoian RK: Integrins and cell proliferation: Regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. J Cell Sci. 114:2553–2560. 2001.PubMed/NCBI
41	Whetton AD and Graham GJ: Homing and mobilization in the stem cell niche. Trends Cell Biol. 9:233–238. 1999. View Article : Google Scholar : PubMed/NCBI
42	Klein G, Beck S and Müller CA: Tenascin is a cytoadhesive extracellular matrix component of the human hematopoietic microenvironment. J Cell Biol. 123:1027–1035. 1993. View Article : Google Scholar : PubMed/NCBI
43	Hsia HC and Schwarzbauer JE: Meet the tenascins: Multifunctional and mysterious. J Biol Chem. 280:26641–26644. 2005. View Article : Google Scholar : PubMed/NCBI
44	Derynck R and Zhang YE: Smad-dependent and Smad-independent pathways in TGF-beta family signaling. Nature. 425:577–584. 2003. View Article : Google Scholar : PubMed/NCBI
45	Itoh Y, Kimoto K, Imaizumi M and Nakatsuka K: Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells. Exp Eye Res. 84:464–472. 2007. View Article : Google Scholar : PubMed/NCBI
46	Gupta N, Su X, Popov B, Lee JW, Serikov V and Matthay MA: Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol. 179:1855–1863. 2007. View Article : Google Scholar : PubMed/NCBI
47	Xu J, Woods CR, Mora AL, Joodi R, Brigham KL, Iyer S and Rojas M: Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am J Physiol Lung Cell Mol Physiol. 293:L131–L141. 2007. View Article : Google Scholar : PubMed/NCBI
48	Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J and Brigham KL: Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol. 33:145–152. 2005. View Article : Google Scholar : PubMed/NCBI